Vincent Grégoire
#152,843
Most Influential Person Now
Vincent Grégoire's AcademicInfluence.com Rankings
Vincent Grégoiremedical Degrees
Medical
#2954
World Rank
#3401
Historical Rank
Radiology
#57
World Rank
#68
Historical Rank

Download Badge
Medical
Why Is Vincent Grégoire Influential?
(Suggest an Edit or Addition)Vincent Grégoire's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. (2004) (663)
- CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. (2003) (640)
- Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (543)
- Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. (2014) (521)
- A gradient-based method for segmenting FDG-PET images: methodology and validation (2007) (422)
- Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. (2003) (397)
- CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. (2015) (369)
- Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. (2000) (350)
- Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. (2006) (331)
- Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. (2008) (321)
- Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. (2012) (310)
- Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. (2011) (273)
- Adaptive radiotherapy of head and neck cancer. (2010) (250)
- Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (240)
- Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. (2010) (215)
- PET-based treatment planning in radiotherapy: a new standard? (2007) (215)
- Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. (2008) (213)
- Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. (2001) (211)
- Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. (2007) (210)
- Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2020) (208)
- State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). (2011) (205)
- Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. (2017) (194)
- Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. (2006) (190)
- Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. (2003) (187)
- International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. (2017) (175)
- The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. (2006) (170)
- Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? (2001) (168)
- Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. (2005) (166)
- Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI. (2005) (164)
- Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. (2007) (164)
- Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies. (1993) (163)
- Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens. (2011) (163)
- Caveolin-1 Expression Is Critical for Vascular Endothelial Growth Factor–Induced Ischemic Hindlimb Collateralization and Nitric Oxide–Mediated Angiogenesis (2004) (160)
- Classification and evaluation strategies of auto‐segmentation approaches for PET: Report of AAPM task group No. 211 (2017) (149)
- Advances in Radiotherapy for Head and Neck Cancer. (2015) (147)
- Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement (2020) (143)
- Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency. (2003) (134)
- Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. (2006) (127)
- Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. (2010) (119)
- Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation. (1998) (115)
- Intensity-modulated radiation therapy for head and neck carcinoma. (2007) (114)
- Oropharyngeal carcinoma related to human papillomavirus (2010) (114)
- Atlas-based delineation of lymph node levels in head and neck computed tomography images. (2008) (112)
- PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. (2015) (112)
- Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. (2002) (111)
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group. (2016) (109)
- Strategies to reduce long‐term postchemoradiation dysphagia in patients with head and neck cancer: An evidence‐based review (2014) (106)
- Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. (2012) (106)
- Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? (2012) (103)
- Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. (2019) (97)
- Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy (2013) (94)
- Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery (2002) (92)
- Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. (2013) (89)
- The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. (2012) (88)
- Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort? (2011) (88)
- A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy (2014) (86)
- Advances in the management of squamous cell carcinoma of the head and neck (2014) (85)
- A pre-clinical assessment of an atlas-based automatic segmentation tool for the head and neck. (2009) (85)
- Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regimens using daily multiple fractions. (2005) (81)
- Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. (2005) (80)
- Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. (2004) (78)
- Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. (2004) (76)
- Nitric oxide as a radiosensitizer: Evidence for an intrinsic role in addition to its effect on oxygen delivery and consumption (2004) (76)
- Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry. (2012) (73)
- Chemo-radiotherapy: radiosensitizing nucleoside analogues (review). (1999) (73)
- A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach. (2013) (72)
- International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma. (2019) (70)
- Is there any future in radiotherapy planning without the use of PET: unraveling the myth... (2004) (67)
- Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. (2004) (67)
- Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. (2015) (65)
- Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma (2009) (62)
- The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. (2009) (59)
- Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: A planning study (2015) (59)
- Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. (2006) (57)
- Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma (2013) (57)
- Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement (2020) (57)
- RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison (2013) (57)
- Effect of chromosome size on aberration levels caused by gamma radiation as detected by fluorescence in situ hybridization. (1994) (55)
- Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. (2009) (55)
- Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth (2015) (52)
- [(18) F]CuCF3 : a [(18) F]trifluoromethylating agent for arylboronic acids and aryl iodides. (2014) (52)
- Clinical use of PET-CT data for radiotherapy planning: what are we looking for? (2010) (52)
- Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. (2006) (50)
- The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. (1994) (50)
- [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model (2009) (49)
- Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis. (1998) (49)
- Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen Consumption (2007) (48)
- De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies (2020) (48)
- Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: a phase II, randomized, double-blind, placebo-controlled study. (2011) (48)
- Treatment of head and neck cancer in the elderly (2010) (47)
- Anatomical bases for the radiological delineation of lymph node areas. Major collecting trunks, head and neck. (2007) (46)
- International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV (2018) (46)
- Nitric oxide-mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses. (2003) (45)
- Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. (2003) (45)
- Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy. (2004) (45)
- The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity. (1999) (45)
- Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-la-Neuve, Belgium. (1996) (45)
- Potentiation of radiation‐induced regrowth delay by isosorbide dinitrate in FSaII murine tumors (2003) (45)
- Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. (1999) (45)
- Impact of cyclic hypoxia on HIF‐1α regulation in endothelial cells – new insights for anti‐tumor treatments (2009) (44)
- Synthesis of [18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia. (2001) (44)
- Decrease in Tumor Cell Oxygen Consumption after Treatment with Vandetanib (ZACTIMA™; ZD6474) and its Effect on Response to Radiotherapy (2009) (42)
- Image guidance in radiation therapy for better cure of cancer (2020) (42)
- Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study (2018) (42)
- Prognostic factors and assessment of staging systems for head and neck soft tissue sarcomas in adults. (2010) (41)
- Biological Basis for Increased Sensitivity to Radiation Therapy in HPV-Positive Head and Neck Cancers (2014) (41)
- Parapharyngeal metastases from thyroid cancer. (2004) (40)
- In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors. (2003) (40)
- Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. (2018) (39)
- Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism (2008) (39)
- Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery (2006) (38)
- Efficient multi-modal dense field non-rigid registration: alignment of histological and section images (2005) (38)
- Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome (2014) (38)
- Edge-Preserving Filtering of Images with Low Photon Counts (2008) (38)
- Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3 (2004) (37)
- Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models. (2010) (37)
- Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities (2006) (35)
- Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation (2014) (35)
- (89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy. (2014) (35)
- PET in radiotherapy planning: particularly exquisite test or pending and experimental tool? (2010) (34)
- Radiomics: Principles and radiotherapy applications. (2019) (33)
- Carbon ion irradiation of the human prostate cancer cell line PC3: A whole genome microarray study (2014) (33)
- Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation (2015) (32)
- Conservation laryngeal surgery for selected pyriform sinus cancer. (2004) (32)
- Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises? (2018) (32)
- Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. (2004) (31)
- Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. (2010) (30)
- Helical tomotherapy for SIB and hypo-fractionated treatments in lung carcinomas: a 4D Monte Carlo treatment planning study. (2012) (30)
- Implementation of hypoxia PET imaging in radiation therapy planning. (2013) (29)
- Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms. (2010) (29)
- Use of 5-[76Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model (2001) (29)
- Effects of irradiation on bone remodelling around mandibular implants: an experimental study in dogs. (2006) (29)
- Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors. (1993) (29)
- Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine. (1994) (29)
- Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors (2011) (28)
- The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck (2014) (28)
- PET imaging biomarkers in head and neck cancer (2015) (28)
- Implant osseointegration in the irradiated mandible. A comparative study in dogs with a microradiographic and histologic assessment. (2002) (28)
- Long-term update of the 24954 EORTC phase III trial on larynx preservation. (2016) (27)
- EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility. (2012) (27)
- Evaluation of MVCT protocols for brain and head and neck tumor patients treated with helical tomotherapy. (2009) (27)
- Dentalmaps: automatic dental delineation for radiotherapy planning in head-and-neck cancer. (2012) (27)
- Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy. (2014) (27)
- Digital pathology: elementary, rapid and reliable automated image analysis (2016) (26)
- Implants placed in an irradiated dog mandible: a morphometric analysis. (2000) (26)
- Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy. (2020) (26)
- The expanding role of fludarabine in hematologic malignancies. (1994) (26)
- Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro. (2002) (26)
- The EORTC module for quality of life in patients with thyroid cancer: phase III. (2017) (26)
- Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation. (1994) (26)
- A Fast Hydrogen Sulfide–Releasing Donor Increases the Tumor Response to Radiotherapy (2015) (25)
- RBE variation between fast neutron beams as a function of energy. Intercomparison involving 7 neutrontherapy facilities. (1996) (25)
- Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma. (1994) (25)
- Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412. (2020) (25)
- Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models. (2008) (25)
- Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors (2016) (25)
- Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis (2006) (25)
- Radiosynthesis and validation of (±)-[18F]-3-fluoro-2-hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors (2017) (24)
- Intensity modulated radiation therapy in head and neck squamous cell carcinoma: state of the art and future challenges. (2005) (24)
- Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach. (2012) (24)
- The role of computational methods for automating and improving clinical target volume definition. (2020) (24)
- First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II. (2010) (23)
- A proposal for redefining the boundaries of level V in the neck: is dissection of the apex of level V necessary in mucosal squamous cell carcinoma of the head and neck? (2002) (23)
- Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How? (2019) (23)
- Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (23)
- Estimation of the deformations induced by articulated bodies: Registration of the spinal column (2007) (22)
- Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83 (2011) (21)
- Determination of tumour hypoxia with the PET tracer [18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model (2007) (21)
- Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the “Best of” Trial (2019) (21)
- Monitoring Tumor Response to Carbogen Breathing by Oxygen-Sensitive Magnetic Resonance Parameters to Predict the Outcome of Radiation Therapy: A Preclinical Study. (2016) (21)
- International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma. (2021) (21)
- Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer. (2019) (21)
- A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. (2002) (21)
- Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer (2020) (21)
- Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance. (2019) (20)
- Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer. (2014) (20)
- Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. (2021) (20)
- Evaluation of the radiobiological impact of anatomic modifications during radiation therapy for head and neck cancer: can we simply summate the dose? (2010) (20)
- Thyroid Status is a Key Modulator of Tumor Oxygenation: Implication for Radiation Therapy (2007) (20)
- Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study. (2015) (20)
- Immobilization device for in vivo and in vitro multimodality image registration of rodent tumors. (2008) (19)
- Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. (2021) (19)
- Higher Initial DNA Damage and Persistent Cell Cycle Arrest after Carbon Ion Irradiation Compared to X-irradiation in Prostate and Colon Cancer Cells (2016) (19)
- Generation of prescriptions robust against geometric uncertainties in dose painting by numbers (2015) (19)
- The potential of helical tomotherapy in the treatment of head and neck cancer. (2013) (19)
- Kinetics of mouse jejunum radiosensitization by 2′,2′-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells (1997) (19)
- Carotid stenting for impending carotid blowout: suitable supportive care for head and neck cancer patients? (2005) (18)
- Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy. (2012) (18)
- High prevalence of SDHB mutations in head and neck paraganglioma in Belgium (2008) (18)
- A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium. (1991) (18)
- Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers. (2019) (17)
- Epithelial–myoepithelial carcinoma of the submandibular gland with symptomatic lung metastases treated with chemotherapy (2006) (17)
- Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of 2-dimensional concepts or a reconsideration of current clinical practice. (2004) (17)
- Effect of intra-peritoneal fludarabine on rat spinal cord tolerance to fractionated irradiation. (1995) (17)
- Preclinical safety and antitumor efficacy of insulin combined with irradiation. (2006) (16)
- Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial (2008) (16)
- Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc (2017) (16)
- Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update (2010) (16)
- Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the delivery of postoperative radiation therapy in complex cutaneous squamous cell carcinoma of the head and neck (cSCCHN). (2020) (16)
- The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. (2003) (15)
- Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure. (2017) (15)
- Non‐invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism (2016) (15)
- Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study? (2020) (15)
- Current practice in proton therapy delivery in adult cancer patients across Europe. (2021) (15)
- New initiatives with fludarabine monophosphate in hematologic malignancies. (1993) (15)
- Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells (2020) (15)
- Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine. (1996) (15)
- Radiobiological intercomparison of p(45)+Be and p(65)+Be neutron beams for lung tolerance in mice after single and fractionated irradiation. (1993) (14)
- Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392). (2005) (14)
- Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy (2003) (14)
- Alginate moulding: an empirical method for magnetic resonance imaging/positron emission tomography co-registration in a tumor rat model. (2008) (14)
- Long-Term In Vivo Monitoring of Adult-Derived Human Liver Stem/Progenitor Cells by Bioluminescence Imaging, Positron Emission Tomography, and Contrast-Enhanced Computed Tomography. (2017) (14)
- Prevalence of lymph nodes in the apex of level V: A plea against the necessity to dissect the apex of level V in mucosal head and neck cancer (2005) (14)
- Synthesis of new 18F-radiolabeled silicon-based nitroimidazole compounds. (2013) (14)
- Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice. (2016) (13)
- Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In Vivo1 (2016) (13)
- KEYNOTE-412: Pembrolizumab (pembro) in combination with chemoradiation versus chemoradiation alone in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). (2017) (13)
- Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study. (2018) (13)
- Effect of gemcitabine on the tolerance of the lung to single-dose irradiation in C3H mice. (1999) (12)
- General principles for prescribing, recording and reporting a therapeutic irradiation. (2004) (12)
- Alteration of the blood-brain barrier after irradiation: implication in boron neutron capture therapy. (1993) (12)
- Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas. (2004) (12)
- Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging. (2013) (12)
- Potentiation of radiotherapy by a localized antiangiogenic gene therapy. (2013) (12)
- Impact of image coregistration with computed tomography (CT), magnetic resonance (MR) and positron emission tomography with fluorodeoxyglucose (FDG-PET) on delineation of GTV’s in oropharyngeal, laryngeal and hypopharyngeal tumors (2002) (11)
- Reprint of "Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2020) (11)
- Use of Xanthinol Nicotinate as a co‐treatment for radio‐ and chemo‐therapy in experimental tumors (2010) (11)
- The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited (2017) (11)
- Preclinical Evaluation of White Led-Activated Non-porphyrinic Photosensitizer OR141 in 3D Tumor Spheroids and Mouse Skin Lesions (2018) (11)
- Evaluation of fully automated a priori MCO treatment planning in VMAT for head-and-neck cancer. (2021) (11)
- Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer (2021) (10)
- Perfluorinated markers for hypoxia detection: synthesis of sulfur-containing precursors and [18F]-labelling. (2005) (10)
- Predictive classifier for intensive treatment of head and neck cancer (2020) (10)
- Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer. (2005) (10)
- Radiobiological intercomparisons of fast neutron beams used in therapy. (1989) (10)
- Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1. (2006) (10)
- UK Head and neck cancer surgical capacity during the second wave of the COVID—19 pandemic: Have we learned the lessons? COVIDSurg collaborative (2021) (10)
- Rodent Rhabdomyosarcoma: Comparison Between Total Choline Concentration at H-MRS and [18F]-fluoromethylcholine Uptake at PET Using Accurate Methods for Collecting Data (2010) (9)
- Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials. (2017) (9)
- Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models (2016) (9)
- Choosing surgery or radiotherapy for oropharyngeal squamous cell carcinoma: is the issue definitely settled? (2019) (9)
- The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model (2020) (9)
- Removal of local field gradient artefacts in BOLD contrast imaging of head and neck tumours. (2002) (8)
- Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic Combinations. (2019) (8)
- [Target-volume selection and delineation in the cervico-maxillo-facial region: beyond the concepts of the ICRU]. (2002) (8)
- First report on the patient database of the identification of the genetic pathways involved in patients overreacting to radiotherapy: GENEPI-II (2009) (8)
- Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless? (2015) (8)
- The increase in tumor oxygenation under carbogen breathing induces a decrease in the uptake of [(18)F]-fluoro-deoxy-glucose. (2015) (8)
- Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium. (2020) (7)
- Radiation-induced apoptosis in tumors: effect of radiation modulating agents. (1997) (7)
- Caveolin-1 Expression Is Critical for VEGF-Induced Ischemic Hindlimb Collateralization and Nitric Oxide – Mediated Angiogenesis (2004) (7)
- Functional image-guided intensity modulated radiation therapy: integration of the tumour microenvironment in treatment planning. (2009) (7)
- Intraoperative validation of CT-based lymph nodal levels, sublevels IIa and IIb: is it of clinical relevance in selective radiation therapy? (2005) (7)
- Clinical implementation of deep-learning based auto-contouring tools-Experience of three French radiotherapy centers. (2021) (7)
- Unmet Needs and Perspectives in Oral Cancer Prevention (2022) (6)
- Radiation Therapy and Management of the Cervical Lymph Nodes and Malignant Skull Base Tumors (2010) (6)
- Early (72‐Hour) detection of radiotherapy‐induced changes in an experimental tumor model using diffusion‐weighted imaging, diffusion tensor imaging, and Q‐space imaging parameters: A comparative study (2012) (6)
- 2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck (2018) (6)
- Radiobiological comparison of fast neutron beams used in therapy. Survey of the published data. (1990) (6)
- Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma: The phase 3 KEYNOTE-412 study. (2018) (6)
- Regarding Davis et al.: Assessment of (18)F PET signals for automatic target volume definition in radiotherapy treatment planning. (2007) (6)
- Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014 (2019) (5)
- Abstract CT163: KEYNOTE-412: Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (2018) (5)
- Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma (2020) (5)
- Tumor reoxygenation following administration of the EGFR inhibitor, gefitinib, in experimental tumors. (2013) (5)
- Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines. (2017) (5)
- DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation. (2016) (5)
- EORTC Radiation Oncology Group: 50 years of continuous accomplishments (2012) (5)
- Atlas-based automatic segmentation (ABAS) of head and neck (H&N) structures in conformal radiotherapy (CRT): Atlas development and preliminary results in clinical context (2007) (5)
- Blood-brain-barrier impairment after irradiation: implication in boron neutron capture therapy. (1989) (5)
- Early monitoring of external radiation therapy by [18F]-fluoromethylcholine positron emission tomography and 3-T proton magnetic resonance spectroscopy: an experimental study in a rodent rhabdomyosarcoma model. (2010) (5)
- KEYNOTE-412: Phase III study of pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (HNSCC). (2018) (5)
- Investigating the potential of deep learning for patient-specific quality assurance of salivary gland contours using EORTC-1219-DAHANCA-29 clinical trial data (2021) (5)
- Technologic Advances in External Beam Radiotherapy for Head and Neck Cancer (2013) (5)
- Molecular-targeted agents for enhancing tumour response (2009) (5)
- Combined radiotherapy and chemotherapy (2009) (5)
- How to minimize morbidity in radiotherapy of pharyngolaryngeal tumors? (2016) (4)
- Variation of Neutron RBE as a Function of Energy for Different Biological Systems: A Review (1992) (4)
- [Recommendations for the definition of target volumes on computerized dosimetry in oropharyngeal cancers]. (2004) (4)
- What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups (2017) (4)
- Impact of hypoxia in head and neck cancer radiotherapy (2017) (4)
- BEST OF: A phase III study assessing the best of radiotherapy (Intensity Modulated RadioTherapy, IMRT) compared to the best of surgery (Trans-Oral Surgery, TOS) in patients with T1-T2, N0 oropharyngeal squamous cell carcinoma (OPSCC). (2018) (4)
- Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: a GORTEC internationally-reviewed HNCIG-endorsed consensus. (2021) (4)
- Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma (2019) (4)
- Time of PTV is ending, robust optimization comes next. (2020) (4)
- The role of gemcitabine-induced cell cycle synchronization in radiosensitization of A SCC61 human head & neck squamous carcinoma cell (HNSCC) line (1997) (4)
- Combined radiotherapy and chemotherapy (2009) (4)
- New challenge of developing combined radio-drug therapy. (2014) (4)
- Selection and Delineation of Lymph Node Target Volumes in Head and Neck Conformal and Intensity-Modulated Radiation Therapy (2004) (4)
- Selection and Delineation of Target Volumes in Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer (2010) (3)
- Early repair kinetics of intestine and lung in mice, after fast neutron and photon irradiation. (1989) (3)
- [Selection and delineation of lymph node target volumes in head and neck neoplasms]. (2001) (3)
- [Impact of reconstructive or minimal invasive surgery on the assessment of current definitions of postoperative clinical target volume for head and neck cancers]. (2020) (3)
- Head and neck multimodality volumes visualization methods (2002) (3)
- [Lymph node metastases from squamous cell carcinoma of unknown primary site. Is it time to change of paradigm?]. (2014) (3)
- Helical tomotherapy in head and neck cancer: a European single-center experience. (2015) (3)
- 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization (2022) (3)
- [Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers]. (2009) (3)
- Chapter 40 – Management of the Neck (2011) (3)
- Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface (2021) (3)
- A Blinded Prospective Evaluation Of Clinical Applicability Of Deep Learning-Based Auto Contouring Of OAR For Head and Neck Radiotherapy (2020) (3)
- Biomarkers of radioresistance in head and neck squamous cell carcinomas (2022) (3)
- Special section on intensity-modulated radiation therapy for head and neck cancer (IMRT). (2019) (3)
- [Present trends in cancer therapy with high-LET radiations] (1996) (3)
- Comparison of atlas-based and deep learning methods for organs at risk delineation on head-and-neck CT images using an automated treatment planning system. (2022) (3)
- Molecular targeted agents for enhancing tumour response (2009) (3)
- 2020 Is 18F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer 14C-EF3 in animal tumour models (2009) (3)
- Radiobiology Studies at Petten: Status on Cell Culture, Mice and Dog Experiments (1992) (3)
- PD-0441 TARGET VOLUME DELINEATION BASED ON 18FDG PET FOR LOCALLY ADVANCED HEAD AND NECK CANCER TREATED BY CHEMO-RADIOTHERAPY (2012) (3)
- Multidisciplinary Management of Hypopharyngeal Carcinoma (2011) (3)
- 392 poster INTERNATIONAL IMRT CREDENTIALING BY PHYSICAL PHANTOM IRRADIATION: THE EORTC ROG EXPERIENCE (2011) (2)
- OC-0278 Accelerated CH-RT with/without nimorazole for p16- HNSCC: the randomized DAHANCA 29-EORTC 1219 trial (2021) (2)
- The role of PET for predicting nodal response in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) treated with chemoradiotherapy (CRT): Results of a prospective multicenter trial. (2017) (2)
- Teaching Session A: Target Volume Selection and Delineation in Head and Neck Tumors: Beyond ICRU Definition. (2007) (2)
- Implementation of intensity-modulated radiation therapy in head and neck tumors: what are the important data for biological optimization? (2004) (2)
- Nuclear Data Relevant to Particle Radiation Therapy Today and to Morrow (1992) (2)
- Conformal radiotherapy in head and neck tumors: increased tumor control and decreased morbidity? (1999) (2)
- Boron Concentration Measurements for the Petten BNCT Project (1992) (2)
- Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results from an EORTC led survey. (2018) (2)
- Concurrent Chemoradiation Therapy Versus Acceleration of Radiation Therapy With or Without Concurrent Chemotherapy in Locally Advanced Head and Neck Carcinoma (GORTEC 99-02): 7-Year Survival Data From a Phase 3 Randomized Trial and Prognostic Factors (2016) (2)
- Comparison of CT- and FDG-PET-defined GT: In regard to Paulino et al. Author's reply (2005) (2)
- 344 MOLECULAR IMAGING IN PLANNING HEAD AND NECK CANCER TREATMENT (2012) (2)
- Oropharyngeal, hypopharyngeal and laryngeal cancer: diagnosis, treatment and follow-up (2015) (2)
- Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure (2021) (2)
- Comparative Pharmacokinetics and Distribution Studies of Boric Acid, L-BPA and BSH in Two Murine Tumour Models (1992) (2)
- Selective irradiation of the neck validation of CT-based neck nodal delineation Rotterdam/Brussels consensus guidelines (2002) (2)
- Editorial: Oropharyngeal carcinoma related to human papillomavirus: Incidence is increasing rapidly, with implications for prognosis and policy (2010) (2)
- Implants placed in irradiated dog's mandible: morphometric examination (1998) (2)
- In regard to Ciernik et al.: Automated functional image-guided radiation treatment planning for rectal cancer (Int J Radiat Oncol Biol Phys 2005;62:893-900). (2006) (2)
- PP27. Cost minimization analysis of treatment of T1N0 glottic squamous cell carcinomas: Comparison between radiotherapy, laser microsurgery and partial laryngectomy (1997) (2)
- [Current data and perspectives on positron emission tomography oncology-radiotherapy]. (1999) (2)
- Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC). (2018) (1)
- Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) (2017) (1)
- Conservation surgery for pyriform sinus cancer (2000) (1)
- International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic (2022) (1)
- Patterns and quality of care for head and neck cancer in Belgium: A population-based study. (2021) (1)
- Salivary gland cancers in elderly patients: challenges and therapeutic strategies (2022) (1)
- Treatment patterns in older patients with locally advanced head and neck squamous cell carcinoma: Results from an EORTC led survey. (2021) (1)
- Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc (2017) (1)
- A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma (2022) (1)
- Arterioles : Implications for Cancer Treatment Endothelin-1 Is a Critical Mediator of Myogenic Tone in Tumor (2004) (1)
- Reply to the letter to the editor from Palazzi et al. (2004) (1)
- 35 Metastatic neck nodal carcinoma of unknown primary: which radiotherapy is needed? (2009) (1)
- Somatic Mutations Induced in Tradescantia By Small Neutron Doses (1984) (1)
- Upright patient positioning for pelvic radiotherapy treatments (2022) (1)
- The Use of Premature Chromosome Condensation and Chromosome Painting to Understand Chromosome Exchange Formation (1994) (1)
- Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma. (2019) (1)
- Impact of Oxygenation Status on 18F-FDG Uptake in Solid Tumors. (2016) (1)
- 182 oral EORTC RADIOTHERAPY QUALITY ASSURANCE PLATFORM: ESTABLISHMENT OF AN INTEGRATED CENTRAL REVIEW FACILITY (2011) (1)
- Improvement of delineation quality of organs at risk in head and neck using the consensus guidelines (2016) (1)
- Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study. (2021) (1)
- PH-0328 Current practice for selection of adult patients for proton therapy across Europe (2021) (1)
- Construction of a Dental Atlas for Automatic Teeth Segmentation to Improve Post-irradiation Dental Care Management (2010) (1)
- Reply to sanguineti regarding the manuscript untitled "Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma". (2021) (1)
- PH-0288: Independent external validation of a logistic regression NTCP model for grade 3 oral mucositis (2020) (0)
- Which imaging is needed for planning head and neck squamous cell carcinoma: a 2004 update (2004) (0)
- Survey of the Adoption of the UICC/AJCC 8th Edition TNM for Head and Neck Cancer: The User’s Initial Experience (2019) (0)
- GD2. The node-negative neck: To operate or not to operate (2011) (0)
- Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-Fluorouracil with or without docetaxel : retrospective analysis of EORTC24971 study (2015) (0)
- 329Effect of 2′,2′-difluorodeoxycytidine (Gemcitabine) on in vivo radiotolerance of mouse jejunum, and its association with the pharmacodynamics of DNA synthesis inhibition (1996) (0)
- List of Referees, 2009 (2010) (0)
- Re-assessment of tumor volume during radiotherapy with anatomic and functional imaging in pharyngolaryngeal SCC: impact on dose distribution (2004) (0)
- Progress in radiotherapy technology for non-radiation oncologists (2007) (0)
- SP-026: Integrating functional imaging in clinical trials (2015) (0)
- In Vitro cellular response of head and neck squamous cell lines exposed to combined docetaxel-radiotherapy (2008) (0)
- PET-tracer for radiotherapy respons: preclinical investigations (2008) (0)
- K6. This house believes that Radiation Oncology should be conformal, tailored and adaptive for the treatment of head and neck tumors (2011) (0)
- Pathology-based verification of head and neck imaging: how far are we from the truth and what are the implications for 3D-CRT and IMRT? (2003) (0)
- SP-0526: Translating hypoxia imaging into adaptive radiotherapy (2014) (0)
- [Comparison of Early Repair Kinetics for Intestine and Lung in Mice After Neutron and Gamma-irradiation] (1985) (0)
- Multi-modality imaging (Computed Tomography, Magnetic Resonance Imaging and Positron Emission Tomography) for radiotherapy planning of pharyngo-laryngeal tumors (2004) (0)
- Molecular image guided radiotherapy (2018) (0)
- Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositis. (2021) (0)
- 71 poster: Iron Oxide Particles Covered with Hexapeptides Targeted at Phosphatidylserine as MR Biomarkers of Tumor Cell Death (2010) (0)
- 46 Therapeutic strategies in t& No Mo glottic carcinomas. A retrospective evaluation (1996) (0)
- Set up accuracy of patients with head and neck tumors using the megavoltage computed tomography imaging capacity of the helical tomotherapy system (2007) (0)
- EP-1923: Integration of microscopic spread and geometric uncertainties into a single target volume expansion (2018) (0)
- MO‐D‐J‐6C‐03: Pathology‐Based Validation of Head and Neck Imaging: How Far Are We From the Truth? (2005) (0)
- SP-0279: The radiation oncologist's view on medical physicists! (2015) (0)
- Principles of radiotherapy (2017) (0)
- SP-013 TNM8: How has the dust settled one year later? (2019) (0)
- Molecular image-guided radiotherapy with positron emission tomography (2009) (0)
- Clinical validation of twelve deformable registration strategies in adaptive radiation therapy for head and neck cancer patients (2008) (0)
- 3:22 pm Response of Endogenous MRI Contrast Metrics (ADC, T2) During Radiotherapy for Prostate Cancer - W. Foltz*, A. Wu, C. Catton, (2010) (0)
- POSTER: PHYSICS TRACK: IMPLEMENTATION OF TECHNOLOGY, TECHNIQUES, CLINICAL PROTOCOLS OR TRIALSPO-0877: QA for radiation therapy in a prospective head & neck study: Outcome impact of ICRs performed by the EORTC QART program (2013) (0)
- Syddansk Universitet Role of radiotherapy fractionation in head and neck cancers ( MARCH ) an updated meta-analysis (2017) (0)
- 682 Validation of CT-based Rotterdam/Brussels neck nodal delineation protocol cranial boundary of level II and relevance for sparing of the parotid gland (2003) (0)
- No statistical impact of intra-tumoral overexpression of EGFR, VEGF and p53 on the overall survival in head and neck squamous cell cancer (HNSCC): Preliminary results of the GORTEC 99–02 randomized trial (2007) (0)
- In reply to "A Long-Awaited Guideline for the Delineation of Primary Tumor in Head and Neck Cancer, and a Few Concerns about It" by Sezin Yuce Sari et al. (2018) (0)
- Management of recurrent and metastatic squamous cell carcinoma of the head and neck (2013) (0)
- Chapter 25 Impact of Oxygenation Status on 18 F-FDG Uptake in Solid Tumors (2016) (0)
- PO-0708: Quality assurance of radiotherapy in the EORTC 1420 Best-of trial. Preliminary results (2018) (0)
- 8515 POSTER DISCUSSION A Dose Escalation Study With Intensity Modulated Radiation Therapy (IMRT) in Moderately Advanced (T2N0, T2N1, T3N0) Squamous Cell Carcinomas (SCC) of the Oropharynx, Larynx and Hypopharynx Using a Simultaneous Integrated Boost (SIB) Approach (2011) (0)
- [Cell-survival Curves - Determining Factors, Models and Concepts] (1994) (0)
- Very Accelerated Radiotherapy (RT) Versus Concomitant Chemo-Radiotherapy (Ct-Rt) In Locally Advanced Head And Neck Cancer: Long Term Results From 2 Phases III GORTEC Randomized Trials (2011) (0)
- 4D validation of dynamic treatment delivery for lung tumors (2012) (0)
- OC-0609: Patient specific plan QA for clinical trial EORTC 1219 using Knowledge-Based Planning (2018) (0)
- SP-0609 INTENSITY MODULATED RADIATION THERAPY (IMRT) FOR HEAD & NECK TUMORS: TOWARD TAILORED AND ADAPTIVE TREATMENTS (2012) (0)
- [Microcinematographic study of the lengthening of the cell cycle after x-ray and fast neutron irradiation]. (1985) (0)
- 440 poster A GRADIENT-BASED SEGMENTATION METHOD FOR FDG-PET BASED GTV DELINEATION: CLINICAL VALIDATION IN NSCLC (2011) (0)
- "Are some green apples less green than others?" (2020) (0)
- Dose painting by numbers: a universal method to ensure the robustness of heterogeneous prescriptions against geometric uncertainties (2013) (0)
- Head and neck proton therapy in France: A missed opportunity or a challenge in front of us? (2021) (0)
- WE-D-BRD-01: Imaging and Treatment Planning for Adaptive Radiotherapy in the Head and Neck (2009) (0)
- 18F-radiolabeling: New methodology and application to hypoxia-related tracers (2009) (0)
- PET-FDG affects staging and patient management in head and neck cancer. A multi-center prospective study (2008) (0)
- TH‐C‐214‐04: This House Believes That the Use of Functional Imaging for Treatment Planning of Head and Neck Tumors Needs to Be Carefully Considered (2011) (0)
- Concomitant association of CDDP-5Fu and radiotherapy for locally advanced laryngeal and pharyngeal squamous cell carcinomas (SCC). A phase II study (1999) (0)
- Topic: PET and RadiotherapyInvited ConferenceIntegration of PET information in Radiation Therapy: present and future clinical applications (2011) (0)
- Target Definition and Delineation CT/MRI/PET-Guided Targets (2009) (0)
- 105 poster: Captopril and S-Nitrosocaptopril as Potent Radiosensitizers: Comparative Study and Underlying Mechanisms. (2010) (0)
- Evidence-based approach to determine meaningful change in scores of the EORTC QLQ-C30 in breast and head and neck cancer : on behalf of the EORTC Breast, Head and Neck and Quality of Life Groups (2018) (0)
- PD-0868 Comparison of segmentation algorithms for organs at risk delineation on head-and-neck CT images (2021) (0)
- RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison (2013) (0)
- 81: Adaptive radiotherapy for head & neck squamous cell carcinoma (2014) (0)
- SP-0227: The immune landscape and immunotherapy for head and neck cancer (2018) (0)
- PD-0134: Hypoxia imaging with 18F-FAZA-PET-CT for adaptive escalation dose for head and neck cancer: A planning study (2014) (0)
- Abstract 4896: Identification of the mechanisms of radiosensitization by human papillomavirus (HPV) in head and neck cancers cell lines (2014) (0)
- Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless? (2015) (0)
- 1106TiPHope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic androgen receptor (AR) expressing SGC (2017) (0)
- High frequency of SDHB mutations in a series of head and neck paraganglioma from Belgium (2006) (0)
- 582 speaker ADAPTIVE TREATMENT WITH HI-ART TOMOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (2011) (0)
- Atlas-based automatic segmentation (ABAS) of head structures in conformal radiation therapy (CRT): atlas development and preliminary results in clinical context (2007) (0)
- 1105TiPPembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial (2017) (0)
- Figure 1 : An Overview of the Recent Evolution in External Beam Radiotherapy (2014) (0)
- OC-0522 Cell-Rad: Towards Histology-driven Radiation Oncology from Multi-Parametric MRI (2021) (0)
- Conservative treatment with combined chemo-radiotherapy for patients with locally advanced pharyngo-laryngeal squamous cell carcinoma: Preserving the organ and its function (2006) (0)
- PO-0951: 18F-FAZA PET as a prognostic marker of the response to radiotherapy in rat tumor models (2014) (0)
- Results of selective neck dissection in the management of head and neck squamous cell carcinoma (2007) (0)
- Tumour shrinkage and adaptive IMRT for head and neck tumor (HNSCC): Where do we stand? (2006) (0)
- Management fo recurrent and metastatic sqamous cell carcinoma of the head and neck (2014) (0)
- EP-1608: FDG-PET based dose painting in head and neck tumors: a dosimetric comparison between TomoTherapy and RapidArc (2014) (0)
- 178Effect of 2′,2′-difluorodeoxycytidine (dFdC) on in vitro radiosensitivity of a radioresistant SQD9 human head and neck squamous carcinoma cell line (1996) (0)
- [Time-lapse Microcinematographic Study of the Cell-cycle Lengthening After Gamma and Fast-neutron Irradiation] (1985) (0)
- Abstract C220: Combining novel targeted therapies and radiotherapy: A challenge to overcome. (2013) (0)
- Adaptive radiotherapy to treatment response (2009) (0)
- Preclinical validation of 2-C-11-thymidine as a cell proliferation marker, in a murine tumor model. (1999) (0)
- 174 Re-assessment of hnscc tumor volume during radiotherapy with anatomic and functional imaging (2006) (0)
- Bone cell vitality around dental implants after irradiation: an experimental study in dog mandibles. (2002) (0)
- SP-0378: PET for delineation in radiotherapy: Reliability and opportunities (2013) (0)
- Evidence against the necessity to dissect the apex of level V in head and neck cancer (2004) (0)
- Hope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of chemotherapy (CT) vs androgen deprivation therapy (ADT) inpatients with recurrent and/or metastatic androgen receptor (AR) expressing SGC (NCT01969578). (2018) (0)
- SP-0522: Dose prescription and treatment delivery at the voxel scale: a fantasy? (2016) (0)
- WHICH IMAGING IS NEEDED FOR PLANNING H&N SQUAMOUS CELL CARCINOMA (2009) (0)
- 22 INVITED Planned neck dissection after chemoradiation for advanced head and neck cancer. Is it always indicated (2007) (0)
- Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma (2021) (0)
- Impact of imaging on the treatment choice in head and neck cancers (2001) (0)
- 18FLT-PET for early treatment adaptation and outcome prediction in head and neck tumors (2010) (0)
- Registration and segmentation of head and neck volumes in IMRT applications (2008) (0)
- 349 QUALITY ASSURANCE IN RADIOTHERAPY: THE EORTC EXPERIENCE (2012) (0)
- Standard vs. adaptive helical tomotherapy in sparing of parotids - series of exploratory calculations (2007) (0)
- Cost-effectiveness in T1N0 glottic squamous cell carcinomas (SCC): Comparison between radiotherapy (RT), laser microsurgery (L) and partial laryngectomy (PL) (1997) (0)
- SP-015: Functional Imaging for Selecting and Monitoring Treatments (2013) (0)
- [Early cell repair of the lung and the intestine in mice, after irradiation by fast neutrons and gamma rays]. (1986) (0)
- Overreactors: definition and value (2008) (0)
- Oc-0507 How Many Chemotherapy Cycles During Chemoradiotherapy for Head and Neck Carcinoma? A Gortec Trial (2012) (0)
- GENEPI-ENTB 2: an infrastructure for the individualisation of radiotherapy (2009) (0)
- Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure (2021) (0)
- SP-0623: Basic principles of ICRU concepts applied to IMRT (2013) (0)
- Conditioning with 8-Gy total body irradiation for allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia (2007) (0)
- 69 Multi-modality imaging for target volume delineation in HNSCC (2006) (0)
- PD-0490: Universal method to ensure robustness of dose painting by numbers prescriptions against geometric uncertainties (2013) (0)
- Characterization of new SDHD mutations in sporadic and familial head and neck paraganglioma from Belgium (2004) (0)
- 488 Selective conformal post-operative radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC). Could the “bath of X-rays” be avoided? (2003) (0)
- 373TiPKEYNOTE-412: Phase 3 trial of pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) (2017) (0)
- Identification of intrinsic and induced differential reactivities of tumor arterioles: new bases for therapeutic strategies targeting the tumor vascularization (2003) (0)
- Indications of external beams radiation for thyroid cancer (2022) (0)
- Adaptive treatment with Hi-Art Tomotherapy for locally advanced head and neck squamous cell carcinoma (2011) (0)
- In Regard to Beadle and Anderson. (2018) (0)
- PET / CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer : (2015) (0)
- SP-0705 Elective nodal irradiation still part of the standard treatment in head and neck cancer (2021) (0)
- OC-0681: Deep learning auto contouring of OAR for HN radiotherapy: a blinded evaluation by clinical experts (2020) (0)
- Modification of the tumor microenvironment by a plasmid encoding an antiangiogenic factor (2008) (0)
- Chapter 38 – Management of the Neck (2012) (0)
- [Improvement of the microcinematography technic for the study of cell cycles]. (1984) (0)
- [Comparative kinetics of the early repair of intestines and lung in mice after fast neutron and gamma-ray irradiation]. (1985) (0)
- Analysis of EGFr, VEGF and p53 in serum of head and neck squamous cell cancer (HNSCC) : Preliminary results of the GORTEC 99-02 randomized trial. (2006) (0)
- L’expérimentation animale reste indispensable (OPINION) (2017) (0)
- 82: An example of the integrated model: the EORTC DAHANCA-1219 trial (2014) (0)
- [Multimodalities imaging for target volume definition in radiotherapy]. (2006) (0)
- Design and use of patient-specific atlases for radiotherapy planning of the head and neck region (2010) (0)
- A comparative study of MRI diffusion-related parameters for the early detection of radiation-induced tissue changes in a rodent tumour model (2009) (0)
- Target volume definition in head and neck squamous cell carcinoma: value of functional imaging (2004) (0)
- Magnetic Resonance Imaging Virtual Histopathology from Weakly Paired Data (2021) (0)
- Hypoxia and perfusion in human head and neck tumors: results with immunohistochemical and image analysis methods employing pimonidazole and IdUrd (2003) (0)
- [Early Repair for Lung and Intestine, in Mice, After Neutron and Gamma-irradiation] (1986) (0)
- SU-E-T-774: on the Effects of Intrafraction Motion on TomoTherapy SIB Treatments of Lung Tumors: A 4D Monte Carlo Study including Non-Rigid Registration and Beamlet-Breathing Phase Correlation (2011) (0)
- Role of chemotherapy in 5 000 patients with head and neck cancer treated by curative surgery: a subgroup analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer (2020) (0)
- PO-0646: Adaptive and robust FDG-PET-based dose painting by numbers (DPBN) in head and neck tumors: a methodological approach (2015) (0)
- SP-0188: General introduction to head and neck radiotherapy (2016) (0)
- 90 speaker LOCALIZE THE ENEMY: IMAGING IN H&N CANCER (2011) (0)
- Do all the linear accelerators comply with the ICRU 91's constraints for stereotactic body radiation therapy treatments? (2019) (0)
- The use of PET imaging for adaptive radiotherapy: Strength and limitation assessed in animal model (2008) (0)
- Multi-modal imaging for dose planning and its benefits: the paradigm of head and neck tumours (2018) (0)
- Comments on the Publication by Corkum et al on “Does 5 + 5 mm Equal Better Radiation Treatment Plans in Head and Neck Cancers?” (2020) (0)
- Calcified tissues histogenesis around dental implants placed in irradiated dog's mandibles. (2000) (0)
- Radiobiological and clinical issues in IMRT for head and neck tumors: what are the important data for biological optimization? (2003) (0)
- Graphical contents list (2013) (0)
- CT-based delineation of lymph node levels and related CTVs in the node-positive and the post-operative neck (2004) (0)
- PO-0788 FEASIBILITY STUDY ON FDG-PET BASED ESCALATED DOSE PAINTING IN HEAD AND NECK TUMORS WITH HELICAL TOMOTHERAPY (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Vincent Grégoire?
Vincent Grégoire is affiliated with the following schools: